Antigenic changes of complement components: relevance for the analysis of complement activation
- PMID: 2472919
- DOI: 10.1159/000463090
Antigenic changes of complement components: relevance for the analysis of complement activation
Abstract
The present paper briefly reviews some general principles in the field of activation-dependent epitopes in the complement cascade. The advantage of monoclonal antibodies in the study of these epitopes is pointed out and available antibodies are listed. Application of such antibodies in reliable and valid assays to detect activation at all levels of the cascade is addressed. The importance of these assay in the study of various pathophysiological and clinical conditions is briefly discussed.
Similar articles
-
Activation-dependent epitopes in the terminal complement pathway.Complement Inflamm. 1989;6(3):223-35. doi: 10.1159/000463096. Complement Inflamm. 1989. PMID: 2472924 Review.
-
Monoclonal antibodies against components of the classical pathway of complement.Complement Inflamm. 1989;6(3):166-74. doi: 10.1159/000463092. Complement Inflamm. 1989. PMID: 2472920 Review.
-
Activation-dependent antigenic changes of human C3.Complement Inflamm. 1989;6(3):205-18. doi: 10.1159/000463094. Complement Inflamm. 1989. PMID: 2472922 Review.
-
Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.Clin Immunol. 2008 Aug;128(2):155-63. doi: 10.1016/j.clim.2008.03.507. Epub 2008 May 23. Clin Immunol. 2008. PMID: 18502181
-
Assessment of complement activation in vivo.Immunopharmacology. 1992 Sep-Oct;24(2):119-34. doi: 10.1016/0162-3109(92)90018-8. Immunopharmacology. 1992. PMID: 1473963 Review.
Cited by
-
Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).Clin Exp Immunol. 1993 Feb;91(2):295-300. doi: 10.1111/j.1365-2249.1993.tb05898.x. Clin Exp Immunol. 1993. PMID: 7679061 Free PMC article.